Substantial x-ray dose reduction capability of the Kinepict Medical Imaging Tool is reviewed and approved by U.S. Food and Drug Administration (FDA) during a 510(k) premarket notification procedure. Link to the record in the FDA database: click here!

Leave a Reply

Your email address will not be published. Required fields are marked *